Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

The GOP is splitting on how to handle the Affordable Care Act. Photo: Jacquelyn Martin/AP

The debate over the Affordable Care Act's cost-sharing subsidies has reopened Republicans' divisions about how to approach the law as a whole: whether to change the law as much as they can; or let it stumble while they keep up a symbolic fight to repeal it.

What we're watching: Congressional Republicans are grappling with two competing proposals from two powerful committee chairmen. Which one is able to gather the most momentum — or whether they end up in a stalemate — will say a lot about whether the party is ready to face the reality that the ACA isn't going anywhere any time soon.

The two bills would both guarantee funding for the ACA's cost-sharing reduction (CSR) payments, but are otherwise extremely different, in both substance and process.

  • HELP Committee Chairman Lamar Alexander's stabilization bill is bipartisan; already has 60 supporters in the Senate; and would essentially trade two years of CSR funding for more state flexibility.
  • The second proposal, put forward by Finance Committee Chairman Orrin Hatch and Ways and Means Chairman Kevin Brady, would also fund the subsidies for two years, but in return for temporarily freezing the individual and employer mandates. No Democrats are expected to support the measure, which means it couldn't pass the Senate.

The divide: To be clear, almost all Republican lawmakers still say they want to repeal the ACA at some point. But in the wake of the party's high-profile failure to pass a repeal bill, the open question is whether to focus for now on smaller-scale reforms that could actually pass.

"There's still a sting from not getting it across the finish line, the repeal and replace, the first time," Sen. Shelley Moore Capito told me. "So I think that's still bubbling up. But then you've got the other issue – the more immediate issue – of fixing the problem. I think that's – I don't want to say controversy, but that's the battle right now."

Two camps:

  • Results and reality:Alexander describes his bill as a "short term, bipartisan plan to reduce premiums and avoid chaos."Sen. Susan Collins, a cosponsor of Alexander's bill: "It has the advantage of being bipartisan and I think that's the approach we need to take."Sen. Mike Rounds, another cosponsor: "We wanted to make sure we got results."
  • Repeal and replace:Speaker Paul Ryan spokesman Doug Andres: "The speaker does not see anything that changes his view that the Senate should keep its focus on repeal and replace of Obamacare."Hatch, in a statement: "If Congress is going to appropriate funds for CSRs, we must include meaningful structural reforms that provide Americans relief from Obamacare."Sen. John Barrasso: "I want to eliminate the mandates, which is not done in Alexander-Murray but is done in Brady-Hatch, so that's the direction I'm heading."
  • Not taking sides:Sen. Thom Tillis: "I encourage both of them...On the one hand, it's good to kind of message to the red meat crowd that's what we want…but at the end of the day, we've got to get an outcome."Sen. John Thune: "Obviously, to repeal all the mandates is something [that'd be] very popular among members. But the question is, is it something that Democrats would vote for. And so right now, like I said, we're kind of in a holding pattern."

The bottom line: "Some Rs want to go back to pre-2010 health care where decisions begin first on policy. Some Rs are stuck in post-2010 health care where decisions are rooted in bitterness and anger," one former GOP aide told me.

Go deeper

Officials warn 5 key tech sectors will determine whether China overtakes U.S.

Illustration: Aïda Amer/Axios

U.S. intelligence officials responsible for protecting advanced technologies have narrowed their focus to five key sectors: artificial intelligence, quantum computing, biotechnology, semiconductors and autonomous systems.

Why it matters: China and Russia are employing a variety of legal and illegal methods to undermine and overtake U.S. dominance in these critical industries, officials warned in a new paper. Their success will determine "whether America remains the world’s leading superpower or is eclipsed by strategic competitors."

3 hours ago - Health

Pfizer says COVID vaccine over 90% effective in kids

A health care worker preparing a Pfizer-BioNTech coronavirus vaccine dose in New York City on Oct. 21. Photo: Michael M. Santiago/Getty Images

Pfizer and BioNTech said their COVID-19 vaccine was more than 90% effective at protecting children between the ages of 5 and 11 from symptomatic infections from the virus, according to a study posted online by the Food and Drug Administration Friday.

Why it matters: Pfizer is seeking an emergency use authorization to vaccinate children — one of the last groups of Americans still largely ineligible to receive a coronavirus vaccine.

Changing the inflation conversation

Illustration: Annelise Capossela/Axios

Inflation looks like it’ll run hot for longer than plenty of smart people thought it would. The conversation over just how much more Americans will have to pay for their stuff has taken on a new intensity, as supply problems show few signs of fading.

Why it matters: The rate of price growth has remained consistently strong in recent months — a time that some thought would bring cooling prices after an initial reopening spike. What goes on with prices will influence the decisions made by Congress, the Biden Administration, and the Federal Reserve.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!